Literature DB >> 20976802

Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium.

Philipp Soergel1, Regine Loehr-Schulz, Marija Hillemanns, Sandra Landwehr, Lars Makowski, Peter Hillemanns.   

Abstract

BACKGROUND AND
OBJECTIVE: Cervical intraepithelial neoplasia (CIN) is associated with genital human papillomavirus (HPV) infection and represents the precursor of cervical cancer. Established ablative treatment methods may cause substantial complications in following pregnancies including premature delivery and the birth of low-weight babies. Photodynamic therapy (PDT) of CIN using esters of 5-aminolevulinic acid (5-ALA) represents a promising alternative. However, it has not been analyzed yet if the PDT itself leads to sustained damage of the cervical tissue. This study aims at evaluating the effect of hexylaminolevulinate (HAL) and methylaminolevulinate (MAL) PDT on cervical tissue. STUDY DESIGN/
MATERIALS AND METHODS: Twenty-five patients underwent 1-2 PDT cycles for CIN 1-3 applying topical HAL and MAL. Before and 6 months after PDT, biopsies were obtained from the cervix. Macroscopic changes of the cervix were evaluated. We assessed H&E slides for signs of sustained tissue damage. Furthermore, expression profiles of p16(INK4a), Ki67, Bcl-2, Bax, and CD31 were evaluated.
RESULTS: PDT was performed satisfactory in all patients. No macroscopic changes of the cervix were encountered and histological evaluation revealed no signs of apoptosis, necrosis, irritation, vascular changes and fibroses 6 months after PDT. Ki67 and p16(INK4a) were useful for the prediction of response to PDT. Bcl-2 and Bax showed no significant expression profile changes after PDT and the micro-vessel pattern was not altered.
CONCLUSIONS: HAL and MAL PDT do not leave any sustained damage in normal cervical tissue. This is of paramount importance as cervical insufficiency or stenosis may have implications on pregnancy and cervical cancer screening.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20976802     DOI: 10.1002/lsm.20979

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  7 in total

1.  Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.

Authors:  Fei Chen; Zoltán Novák; Christian Dannecker; Ctirad Mokráš; Long Sui; Youzhong Zhang; Zhixue You; Ling Han; Jinghe Lang; Peter Hillemanns
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

Review 2.  Biomodulatory approaches to photodynamic therapy for solid tumors.

Authors:  Sanjay Anand; Bernhard J Ortel; Stephen P Pereira; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

Review 3.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

4.  In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer.

Authors:  Sami El Khatib
Journal:  Curr Urol       Date:  2021-03-29

5.  Efficacy of commercially available biological agents for the topical treatment of cervical intraepithelial neoplasia: a systematic review.

Authors:  Alex Baleka Mutombo; Cindy Simoens; Rahma Tozin; Johannes Bogers; Jean-Pierre Van Geertruyden; Yves Jacquemyn
Journal:  Syst Rev       Date:  2019-06-07

6.  Long Term Effectiveness of Photodynamic Therapy for CIN Treatment.

Authors:  Natalia Mayumi Inada; Hilde Harb Buzzá; Marieli Fernanda Martins Leite; Cristina Kurachi; Jose Roberto Trujillo; Cynthia Aparecida de Castro; Fernanda Mansano Carbinatto; Welington Lombardi; Vanderlei Salvador Bagnato
Journal:  Pharmaceuticals (Basel)       Date:  2019-07-12

7.  Bioadhesive mini-tablets for vaginal drug delivery.

Authors:  Marianne Hiorth; Susanne Nilsen; Ingunn Tho
Journal:  Pharmaceutics       Date:  2014-08-27       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.